Recent News

• 04.22.2025 - Statutory auditor mandate
• 04.16.2025 - Conditional Issuance of Shares
• 04.08.2025 - Nyxoah Provides Update on FDA Approvable Letter for Genio System
• 03.26.2025 - FDA Issues Nyxoah an Approvable Letter for its Genio® System
• 03.20.2025 - Nyxoah Annual Report 2024 (XBRI)
• 03.20.2025 - Nyxoah Annual Report 2024 (XHTML)
• 03.20.2025 - Nyxoah Annual Report 2024 (FR)
• 03.20.2025 - Nyxoah Annual Report 2024 (ENG)
• 03.20.2025 - Nyxoah Annual Report 2024
• 03.19.2025 - Nyxoah Investor Presentation

Recent Filings

• 04.16.2025 - EX-99.1 EX-99.1
• 04.16.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.08.2025 - EX-99.1 EX-99.1
• 04.08.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.01.2025 - EFFECT Notice of Effectiveness
• 03.26.2025 - EX-99.1 EX-99.1
• 03.26.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.20.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.20.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.20.2025 - F-3 Registration statement by foreign private issuers